(Q48545863)

12 February 2018

reason for preferred rank

title

Indole-N-methylated β-carbolinium ions as potential brain-bioactivated neurotoxins (English)

1 reference

https://api.crossref.org/works/10.1016/0006-8993(92)90576-U

16 October 2022

Indole-N-methylated beta-carbolinium ions as potential brain-bioactivated neurotoxins (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1617407

16 October 2022

author name string

Cobuzzi RJ Jr

4

1 reference

12 February 2018

M. A. Collins

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1617407

16 October 2022

E. J. Neafsey

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1617407

16 October 2022

K. Matsubara

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1617407

16 October 2022

R. J. Cobuzzi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1617407

16 October 2022

H. Rollema

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1617407

16 October 2022

language of work or name

English

0 references

publication date

1 January 1992

1 reference

12 February 2018

20 January 1992

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1617407

full work available at URL

16 October 2022

https://api.elsevier.com/content/article/PII:000689939290576U?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0006-8993(92)90576-U

https://api.elsevier.com/content/article/PII:000689939290576U?httpAccept=text/plain

16 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-8993(92)90576-U

16 October 2022

1 reference

12 February 2018

volume

570

1 reference

12 February 2018

issue

1-2

1 reference

12 February 2018

page(s)

154-160

1 reference

12 February 2018

Role of N-methyltransferases in the neurotoxicity associated with the metabolites of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and other 4-substituted pyridines present in the environment

cites work

3

1 reference

https://api.crossref.org/works/10.1016/0006-8993(92)90576-U

Harman in rat brain, lung and human CSF: effect of alcohol consumption

16 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0006-8993(92)90576-U

Beta-carboline analogues of N-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP): endogenous factors underlying idiopathic parkinsonism?

16 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0006-8993(92)90576-U

Reevaluation of the products of tryptamine catalyzed by rabbit liver N-methyltransferases

16 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0006-8993(92)90576-U

Formation of quaternary amines by N- methylation of azaheterocycles with homogeneous amine n-methyltransferases

16 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0006-8993(92)90576-U

A dopaminergic cell line variant resistant to the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

16 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0006-8993(92)90576-U

Dopamine uptake inhibitory capacities of beta-carboline and 3,4-dihydro-beta-carboline analogs of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) oxidation products.

16 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0006-8993(92)90576-U

The genetics of Parkinson's disease: a reconsideration

16 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0006-8993(92)90576-U

Inhibition of MAO by β-Carbolinium Halides

16 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/0006-8993(92)90576-U

Inhibition of mitochondrial respiration by analogs of 4-phenylpyridine and 1-methyl-4-phenylpyridinium cation (MPP+), the neurotoxic metabolite of MPTP

16 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0006-8993(92)90576-U

The MPTP story: MAO activates tetrahydropyridine derivatives to toxins causing parkinsonism

16 October 2022

20

1 reference

https://api.crossref.org/works/10.1016/0006-8993(92)90576-U

Evaluation of the toxicity of the dopaminergic neurotoxins MPTP and MPP+ in PC12 pheochromocytoma cells: binding and biological studies

16 October 2022

21

1 reference

https://api.crossref.org/works/10.1016/0006-8993(92)90576-U

Prevention of the nigrostriatal toxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by inhibitors of 3,4-dihydroxyphenylethylamine transport

16 October 2022

23

1 reference

https://api.crossref.org/works/10.1016/0006-8993(92)90576-U

A N-methyltransferase in human brain catalyses N-methylation of 1,2,3,4-tetrahydroisoquinoline into N-methyl-1,2,3,4-tetrahydroisoquinoline, a precursor of a dopaminergic neurotoxin, N-methylisoquinolinium ion

16 October 2022

24

1 reference

https://api.crossref.org/works/10.1016/0006-8993(92)90576-U

Effect of N-methyl-4-phenylpyridinium ion on monoamine oxidase in a clonal rat pheochromocytoma cell line, PC12h

16 October 2022

25

1 reference

https://api.crossref.org/works/10.1016/0006-8993(92)90576-U

Striatal dopaminergic toxicity following intranigral injection in rats of 2-methyl-norharman, a beta-carbolinium analog of N-methyl-4-phenylpyridinium ion (MPP+).

16 October 2022

26

1 reference

https://api.crossref.org/works/10.1016/0006-8993(92)90576-U

Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine

16 October 2022

27

1 reference

https://api.crossref.org/works/10.1016/0006-8993(92)90576-U

In vivo dopaminergic neurotoxicity of the 2-beta-methylcarbolinium ion, a potential endogenous MPP+ analog

16 October 2022

28

1 reference

https://api.crossref.org/works/10.1016/0006-8993(92)90576-U

In vivo intracerebral microdialysis studies in rats of MPP+ analogues and related charged species.

16 October 2022

30

1 reference

https://api.crossref.org/works/10.1016/0006-8993(92)90576-U

Biochemical mechanism of action of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

16 October 2022

33

1 reference

https://api.crossref.org/works/10.1016/0006-8993(92)90576-U

Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease

16 October 2022

34

1 reference

https://api.crossref.org/works/10.1016/0006-8993(92)90576-U

Endogenously formed norharman (beta-carboline) in platelet rich plasma obtained from porphyric rats

16 October 2022

35

1 reference

https://api.crossref.org/works/10.1016/0006-8993(92)90576-U

Mechanism of the neurotoxicity of MPTP. An update

16 October 2022

36

1 reference

https://api.crossref.org/works/10.1016/0006-8993(92)90576-U

Xenobiotic metabolism in Parkinson's disease

16 October 2022

37

1 reference

https://api.crossref.org/works/10.1016/0006-8993(92)90576-U

Do environmental toxins cause Parkinson's disease? A critical review

16 October 2022

38

1 reference

https://api.crossref.org/works/10.1016/0006-8993(92)90576-U

Does an endogenous methylpyridinium analogue cause Parkinson's disease?

16 October 2022

39

1 reference

https://api.crossref.org/works/10.1016/0006-8993(92)90576-U

16 October 2022

Identifiers

1 reference

12 February 2018

1 reference

12 February 2018